Literature DB >> 7585008

Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.

T H Finkel1, G Tudor-Williams, N K Banda, M F Cotton, T Curiel, C Monks, T W Baba, R M Ruprecht, A Kupfer.   

Abstract

Although 13 years have passed since identification of human immunodeficiency virus-1 (HIV-1) as the cause of AIDS, we do not yet know how HIV kills its primary target, the T cell that carries the CD4 antigen. We and others have shown an increase in the percentage of apoptotic cells among circulating CD4+ (and CD8+) T cells of HIV-seropositive individuals and an increase in frequency of apoptosis with disease progression. However, it is not known if this apoptosis occurs in infected or uninfected T cells. We show here, using in situ labelling of lymph nodes from HIV-infected children and SIV-infected macaques, that apoptosis occurs predominantly in bystander cells and not in the productively infected cells themselves. These data have implications for pathogenesis and therapy, namely, arguing that rational drug therapy may involve combination agents targeting viral replication in infected cells and apoptosis of uninfected cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585008     DOI: 10.1038/nm0295-129

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  286 in total

1.  Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine.

Authors:  R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death.

Authors:  S J Brodie; B K Patterson; D A Lewinsohn; K Diem; D Spach; P D Greenberg; S R Riddell; L Corey
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection.

Authors:  R S Veazey; K G Mansfield; I C Tham; A C Carville; D E Shvetz; A E Forand; A A Lackner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Role of antiretroviral regimes in HIV-1 patients in reducing immune activation.

Authors:  Antonio Jiménez; Laura Molero; Ana Jiménez; Susana Castañón; Dolores Subirá; Miguel De Górgolas; Manuel Fedz-Guerrero; Rosa García
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

5.  Human immunodeficiency virus type 1 induces apoptosis in CD4(+) but not in CD8(+) T cells in ex vivo-infected human lymphoid tissue.

Authors:  J C Grivel; N Malkevitch; L Margolis
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.

Authors:  B Etemad-Moghadam; D Rhone; T Steenbeke; Y Sun; J Manola; R Gelman; J W Fanton; P Racz; K Tenner-Racz; M K Axthelm; N L Letvin; J Sodroski
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

7.  Late-emerging strains of HIV induce T-cell homeostasis failure by promoting bystander cell death and immune exhaustion in naïve CD4 and all CD8 T-cells.

Authors:  Catherine N Kibirige; Frederick A Menendez; Hao Zhang; Tricia L Nilles; Susan Langan; Joseph B Margolick
Journal:  Med Hypotheses       Date:  2014-04-13       Impact factor: 1.538

8.  Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection.

Authors:  Marc K Hellerstein; Rebecca A Hoh; Mary Beth Hanley; Denise Cesar; Daniel Lee; Richard A Neese; Joseph M McCune
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  Turnover of lymphocytes and conceptual paradigms in HIV infection.

Authors:  Guido Silvestri; Mark B Feinberg
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.

Authors:  Mireille Laforge; Ricardo Silvestre; Vasco Rodrigues; Julie Garibal; Laure Campillo-Gimenez; Shahul Mouhamad; Valérie Monceaux; Marie-Christine Cumont; Henintsoa Rabezanahary; Alain Pruvost; Anabela Cordeiro-da-Silva; Bruno Hurtrel; Guido Silvestri; Anna Senik; Jérôme Estaquier
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.